Assessment of postoperative adjuvant treatment using toceranib phosphate against adenocarcinoma in dogs
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Veterinary Internal Medicine"
DOI: 10.1111/jvim.15768
Abstract: Abstract Background Toceranib phosphate (TOC) could be made widely available for treating tumors in dogs if evidence shows that TOC inhibits recurrence after surgery. Objectives To investigate how postoperative adjuvant treatment with TOC modulates the… read more here.
Keywords: surgery; postoperative adjuvant; adjuvant treatment; treated surgery ... See more keywords
Discovery of canine drug toceranib phosphate as a repurposed agent against human hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Liver International"
DOI: 10.1111/liv.15540
Abstract: Human hepatocellular carcinoma (HCC) is an aggressive malignancy with poor clinical outcomes. There are limited therapeutic options for those diagnosed with terminal HCC and therefore incorporating novel agents into standard‐of‐care regimens is urgently needed. In… read more here.
Keywords: hepatocellular carcinoma; human hepatocellular; toceranib phosphate; drug ... See more keywords
Response and outcome following toceranib phosphate treatment for stage four anal sac apocrine gland adenocarcinoma in dogs: 15 cases (2013-2017).
Sign Up to like & getrecommendations! Published in 2019 at "Journal of the American Veterinary Medical Association"
DOI: 10.2460/javma.254.8.960
Abstract: OBJECTIVE To assess response and outcome in dogs with stage 4 anal sac apocrine gland adenocarcinoma (ASAGA) treated with toceranib phosphate as the sole chemotherapeutic agent. DESIGN Retrospective case series. ANIMALS 15 client-owned dogs with… read more here.
Keywords: stage; response; treatment; anal sac ... See more keywords